The Hydration Pharmaceuticals Company Ltd
The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. The company sells its products under the Hydralyte brand through retail stores and online. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is based in Melbourne, Australi… Read more
The Hydration Pharmaceuticals Company Ltd (HPC) - Total Assets
Latest total assets as of June 2025: AU$3.93 Million AUD
Based on the latest financial reports, The Hydration Pharmaceuticals Company Ltd (HPC) holds total assets worth AU$3.93 Million AUD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
The Hydration Pharmaceuticals Company Ltd - Total Assets Trend (2018–2024)
This chart illustrates how The Hydration Pharmaceuticals Company Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
The Hydration Pharmaceuticals Company Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
The Hydration Pharmaceuticals Company Ltd's total assets of AU$3.93 Million consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 64.4% |
| Accounts Receivable | AU$352.69K | 7.1% |
| Inventory | AU$1.10 Million | 21.9% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how The Hydration Pharmaceuticals Company Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: The Hydration Pharmaceuticals Company Ltd's current assets represent 100.0% of total assets in 2024, unchanged from 100.0% in 2018.
- Cash Position: Cash and equivalents constituted 64.4% of total assets in 2024, up from 59.8% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is inventory at 21.9% of total assets.
The Hydration Pharmaceuticals Company Ltd Competitors by Total Assets
Key competitors of The Hydration Pharmaceuticals Company Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen Agricultural Products Co Ltd
SHE:000061
|
China | CN¥23.90 Billion |
|
Maiquer Group Co Ltd
SHE:002719
|
China | CN¥1.09 Billion |
|
Jinzi Ham Co Ltd
SHE:002515
|
China | CN¥2.67 Billion |
|
Dongwon Ind
KO:006040
|
Korea | ₩7.56 Trillion |
|
SCC Holdings Bhd
KLSE:0158
|
Malaysia | RM55.24 Million |
|
Kim Teck Cheong Consolidated Bhd
KLSE:0180
|
Malaysia | RM522.43 Million |
|
Dongsuh
KO:026960
|
Korea | ₩1.77 Trillion |
|
Wellspire Holdings Berhad
KLSE:0271
|
Malaysia | RM68.85 Million |
The Hydration Pharmaceuticals Company Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - The Hydration Pharmaceuticals Company Ltd generates 0.64x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, The Hydration Pharmaceuticals Company Ltd generates $ 53.39 in net profit.
The Hydration Pharmaceuticals Company Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.27 | 1.53 | 2.53 |
| Quick Ratio | 2.43 | 0.83 | 1.98 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$2.73 Million | AU$ 1.96 Million | AU$ 2.55 Million |
The Hydration Pharmaceuticals Company Ltd - Advanced Valuation Insights
This section examines the relationship between The Hydration Pharmaceuticals Company Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.72 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | -25.3% |
| Total Assets | AU$5.00 Million |
| Market Capitalization | $545.86K USD |
Valuation Analysis
Below Book Valuation: The market values The Hydration Pharmaceuticals Company Ltd's assets below their book value (0.11 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: The Hydration Pharmaceuticals Company Ltd's assets decreased by 25.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for The Hydration Pharmaceuticals Company Ltd (2018–2024)
The table below shows the annual total assets of The Hydration Pharmaceuticals Company Ltd from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | AU$5.00 Million | -25.33% |
| 2023-12-31 | AU$6.69 Million | -35.60% |
| 2022-12-31 | AU$10.39 Million | -32.11% |
| 2021-12-31 | AU$15.31 Million | +244.27% |
| 2020-12-31 | AU$4.45 Million | +5.85% |
| 2019-12-31 | AU$4.20 Million | -0.96% |
| 2018-12-31 | AU$4.24 Million | -- |